Page last updated: 2024-11-08

flavipucine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

flavipucine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10444160
CHEMBL ID62236
MeSH IDM0043655

Synonyms (2)

Synonym
flavipucine
CHEMBL62236
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID1593652Cytotoxicity against human HEK293 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID94052Tested in vitro for antibacterial activity against Klebsiella pneumoniae1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID206317Tested in vitro for antibacterial activity against Staphylococcus aureus1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID1593646Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593648Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID35541Tested for antifungal activity against Alternaria solani1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID1593647Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID69827Tested in vitro for antibacterial activity against Escherichia coli1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID37720Tested for antifungal activity against Aspergillus niger1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID1593649Cytotoxicity against human TE8 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID163426Tested in vitro for antibacterial activity against Pseudomonas aeruginosa1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID33215Tested in vitro for antibacterial activity against Aerobacter aerogenes1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID1593651Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593653Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593645Bactericidal activity against Bacillus subtilis NBRC 3134 incubated for 18 hrs followed by inoculums transfer to MHA plate and further incubated for 24 hrs2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593643Antibacterial activity against Escherichia coli NBRC 3301 after 17 hrs by broth microdilution method2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593650Cytotoxicity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by WST8 dye based assay2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID163555Tested in vitro for antibacterial activity against Proteus volgaris1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
AID1593642Bactericidal activity against Escherichia coli NBRC 3301 incubated for 17 hrs followed by inoculums transfer to MHA plate and further incubated for 24 hrs2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID1593644Antibacterial activity against Bacillus subtilis NBRC 3134 after 18 hrs by broth microdilution method2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
AID42648Tested in vitro for antibacterial activity against Bordetella bronchiseptica1980Journal of medicinal chemistry, Feb, Volume: 23, Issue:2
Synthesis and biological activity of flavipucine analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]